Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Dec;143(6):1621–1633.

Acute side effects of homologous interleukin-3 in rhesus monkeys.

F C van Gils 1, A H Mulder 1, C van den Bos 1, H Burger 1, R W van Leen 1, G Wagemaker 1
PMCID: PMC1887280  PMID: 8256852

Abstract

Interleukin-3 treatment of juvenile rhesus monkeys elicits a dose- and time-dependent syndrome that includes urticaria, palpable lymph nodes, splenomegaly, thrombocytopenia, anemia, vomiting, diarrhea, intestinal bleeding, edema, and arthritis, apart from a strong stimulation of hemopoiesis. Arthritis was found to occur significantly more often in animals expressing the major histocompatibility complex alleles B9 and Dr5. Histological analysis revealed an abundance of mast cells in urticaria and, to a lesser extent, in lungs and synovia of arthritic joints. Active osteoclasts were abundant in ribs and arthritic joints. Extramedullary hemopoiesis was encountered in liver, spleen, and kidneys. The spleen showed deposits of hemosiderin, and in the liver, Kupffer cells were loaded with iron, indicating enhanced turnover of hemoglobin. Lymph nodes and bone marrow showed macrophages involved in hemophagocytosis, which probably contributed to the development of anemia and thrombopenia. Biochemical parameters in sera were indicative of parenchymal liver damage, with cholestasis and increased erythrocyte destruction. The side effects were strongly reduced in monkeys subjected to total body irradiation just before interleukin-3 treatment. Histamine antagonists were not significantly effective in preventing side effects, which is explained by the perpetual stimulation of basophilic granulocytes by exogenous interleukin-3. The nature of the side effects indicates that interleukin-3 may be involved in the pathogenesis of acute type hypersensitivity reactions and arthritis.

Full text

PDF
1621

Images in this article

1624Figure 1
on p.1624
1626Figure 2
on p.1626
1629Figure 3
on p.1629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker N. P., van Erck M. G., Otting N., Lardy N. M., Noort R. C., 't Hart B. A., Jonker M., Bontrop R. E. Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region. J Exp Med. 1992 Apr 1;175(4):933–937. doi: 10.1084/jem.175.4.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barton B. E., Mayer R. IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells. J Immunol. 1989 Nov 15;143(10):3211–3216. [PubMed] [Google Scholar]
  3. Bernstein I. D., Andrews R. G., Zsebo K. M. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood. 1991 Jun 1;77(11):2316–2321. [PubMed] [Google Scholar]
  4. Bischoff S. C., Dahinden C. A. c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med. 1992 Jan 1;175(1):237–244. doi: 10.1084/jem.175.1.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bot F. J., Dorssers L., Wagemaker G., Löwenberg B. Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: importance of accessory cells. Blood. 1988 Jun;71(6):1609–1614. [PubMed] [Google Scholar]
  6. Briddell R. A., Brandt J. E., Leemhuis T. B., Hoffman R. Role of cytokines in sustaining long-term human megakaryocytopoiesis in vitro. Blood. 1992 Jan 15;79(2):332–337. [PubMed] [Google Scholar]
  7. Briddell R. A., Bruno E., Cooper R. J., Brandt J. E., Hoffman R. Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood. 1991 Dec 1;78(11):2854–2859. [PubMed] [Google Scholar]
  8. Briddell R. A., Hoffman R. Cytokine regulation of the human burst-forming unit-megakaryocyte. Blood. 1990 Aug 1;76(3):516–522. [PubMed] [Google Scholar]
  9. Bridges A. J., Malone D. G., Jicinsky J., Chen M., Ory P., Engber W., Graziano F. M. Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy. Arthritis Rheum. 1991 Sep;34(9):1116–1124. doi: 10.1002/art.1780340907. [DOI] [PubMed] [Google Scholar]
  10. Bromley M., Fisher W. D., Woolley D. E. Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis. 1984 Feb;43(1):76–79. doi: 10.1136/ard.43.1.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bromley M., Woolley D. E. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum. 1984 Sep;27(9):968–975. doi: 10.1002/art.1780270902. [DOI] [PubMed] [Google Scholar]
  12. Bruno E., Cooper R. J., Briddell R. A., Hoffman R. Further examination of the effects of recombinant cytokines on the proliferation of human megakaryocyte progenitor cells. Blood. 1991 Jun 1;77(11):2339–2346. [PubMed] [Google Scholar]
  13. Budel L. M., Elbaz O., Hoogerbrugge H., Delwel R., Mahmoud L. A., Löwenberg B., Touw I. P. Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes. Blood. 1990 Apr 1;75(7):1439–1445. [PubMed] [Google Scholar]
  14. Burger H., van Leen R. W., Dorssers L. C., Persoon N. L., Lemson P. J., Wagemaker G. Species specificity of human interleukin-3 demonstrated by cloning and expression of the homologous rhesus monkey (Macaca mulatta) gene. Blood. 1990 Dec 1;76(11):2229–2234. [PubMed] [Google Scholar]
  15. Byron J. W. Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cell. Agents Actions. 1977 Jul;7(2):209–213. doi: 10.1007/BF01969974. [DOI] [PubMed] [Google Scholar]
  16. Byron J. W. Pharmacodynamic basis for the interaction of cimetidine with the bone marrow stem cells (CFUS). Exp Hematol. 1980 Mar;8(3):256–263. [PubMed] [Google Scholar]
  17. Chang J. M., Metcalf D., Lang R. A., Gonda T. J., Johnson G. R. Nonneoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression. Blood. 1989 May 1;73(6):1487–1497. [PubMed] [Google Scholar]
  18. Cherner J. A., Jensen R. T., Dubois A., O'Dorisio T. M., Gardner J. D., Metcalfe D. D. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology. 1988 Sep;95(3):657–667. doi: 10.1016/s0016-5085(88)80012-x. [DOI] [PubMed] [Google Scholar]
  19. Clutterbuck E. J., Hirst E. M., Sanderson C. J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood. 1989 May 1;73(6):1504–1512. [PubMed] [Google Scholar]
  20. Clutterbuck E. J., Sanderson C. J. Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor. Blood. 1990 May 1;75(9):1774–1779. [PubMed] [Google Scholar]
  21. Crisp A. J., Chapman C. M., Kirkham S. E., Schiller A. L., Krane S. M. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum. 1984 Aug;27(8):845–851. doi: 10.1002/art.1780270802. [DOI] [PubMed] [Google Scholar]
  22. Crisp A. J. Mast cells in rheumatoid arthritis. J R Soc Med. 1984 Jun;77(6):450–451. doi: 10.1177/014107688407700602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Donahue R. E., Seehra J., Metzger M., Lefebvre D., Rock B., Carbone S., Nathan D. G., Garnick M., Sehgal P. K., Laston D. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science. 1988 Sep 30;241(4874):1820–1823. doi: 10.1126/science.3051378. [DOI] [PubMed] [Google Scholar]
  24. Elliott M. J., Vadas M. A., Cleland L. G., Gamble J. R., Lopez A. F. IL-3 and granulocyte-macrophage colony-stimulating factor stimulate two distinct phases of adhesion in human monocytes. J Immunol. 1990 Jul 1;145(1):167–176. [PubMed] [Google Scholar]
  25. Ema H., Suda T., Miura Y., Nakauchi H. Colony formation of clone-sorted human hematopoietic progenitors. Blood. 1990 May 15;75(10):1941–1946. [PubMed] [Google Scholar]
  26. Ema H., Suda T., Nagayoshi K., Miura Y., Civin C. I., Nakauchi H. Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils. Blood. 1990 Nov 15;76(10):1956–1961. [PubMed] [Google Scholar]
  27. Fabian I., Kletter Y., Mor S., Geller-Bernstein C., Ben-Yaakov M., Volovitz B., Golde D. W. Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL-1, IL-3, IL-5 and GM-CSF. Br J Haematol. 1992 Feb;80(2):137–143. doi: 10.1111/j.1365-2141.1992.tb08890.x. [DOI] [PubMed] [Google Scholar]
  28. Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C. J., Gleich G. J. Regulatory effect of cytokines on eosinophil degranulation. J Immunol. 1990 Jan 15;144(2):642–646. [PubMed] [Google Scholar]
  29. Ganser A., Lindemann A., Seipelt G., Ottmann O. G., Eder M., Falk S., Herrmann F., Kaltwasser J. P., Meusers P., Klausmann M. Effects of recombinant human interleukin-3 in aplastic anemia. Blood. 1990 Oct 1;76(7):1287–1292. [PubMed] [Google Scholar]
  30. Ganser A., Lindemann A., Seipelt G., Ottmann O. G., Herrmann F., Eder M., Frisch J., Schulz G., Mertelsmann R., Hoelzer D. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood. 1990 Aug 15;76(4):666–676. [PubMed] [Google Scholar]
  31. Ganser A., Seipelt G., Lindemann A., Ottmann O. G., Falk S., Eder M., Herrmann F., Becher R., Höffken K., Büchner T. Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood. 1990 Aug 1;76(3):455–462. [PubMed] [Google Scholar]
  32. Grennan D. M. Histamine receptors in the synovial microcirculation. Eur J Clin Invest. 1975 Feb;5(1):75–82. doi: 10.1111/j.1365-2362.1975.tb00431.x. [DOI] [PubMed] [Google Scholar]
  33. Grundfest S., Cooperman A. M., Ferguson R., Benjamin S. Portal hypertension associated with systemic mastocytosis and splenomegaly. Gastroenterology. 1980 Feb;78(2):370–373. [PubMed] [Google Scholar]
  34. Hattersley G., Chambers T. J. Effects of interleukin 3 and of granulocyte-macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue. J Cell Physiol. 1990 Jan;142(1):201–209. doi: 10.1002/jcp.1041420125. [DOI] [PubMed] [Google Scholar]
  35. Heidt P. J., van der Waaij D., Vossen J. M., Hendriks W. D. The use of a human donor flora for recontamination following antibiotic decontamination. Prog Food Nutr Sci. 1983;7(3-4):53–63. [PubMed] [Google Scholar]
  36. Horny H. P., Ruck M., Wehrmann M., Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haematol. 1990 Oct;76(2):186–193. doi: 10.1111/j.1365-2141.1990.tb07870.x. [DOI] [PubMed] [Google Scholar]
  37. Imashuku S., Hibi S. Cytokines in hemophagocytic syndrome. Br J Haematol. 1991 Mar;77(3):438–440. doi: 10.1111/j.1365-2141.1991.tb08600.x. [DOI] [PubMed] [Google Scholar]
  38. Kirshenbaum A. S., Dreskin S. C., Metcalfe D. D. A staphylococcal protein A rosetting assay for the demonstration of high affinity IgE receptors on rIL-3-dependent human basophil-like cells grown in mixed cell cultures. J Immunol Methods. 1989 Sep 29;123(1):55–62. doi: 10.1016/0022-1759(89)90029-x. [DOI] [PubMed] [Google Scholar]
  39. Kirshenbaum A. S., Goff J. P., Dreskin S. C., Irani A. M., Schwartz L. B., Metcalfe D. D. IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. J Immunol. 1989 Apr 1;142(7):2424–2429. [PubMed] [Google Scholar]
  40. Kirshenbaum A. S., Kessler S. W., Goff J. P., Metcalfe D. D. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol. 1991 Mar 1;146(5):1410–1415. [PubMed] [Google Scholar]
  41. Kurzrock R., Talpaz M., Estrov Z., Rosenblum M. G., Gutterman J. U. Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J Clin Oncol. 1991 Jul;9(7):1241–1250. doi: 10.1200/JCO.1991.9.7.1241. [DOI] [PubMed] [Google Scholar]
  42. Leary A. G., Ikebuchi K., Hirai Y., Wong G. G., Yang Y. C., Clark S. C., Ogawa M. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha. Blood. 1988 Jun;71(6):1759–1763. [PubMed] [Google Scholar]
  43. Lemanske R. F., Jr, Barr L., Guthman D. A., Kaliner M. The biologic activity of mast cell granules. V. The effects of antihistamine treatment on rat cutaneous early- and late-phase allergic reactions. J Allergy Clin Immunol. 1983 Jul;72(1):94–99. doi: 10.1016/0091-6749(83)90058-1. [DOI] [PubMed] [Google Scholar]
  44. Lindsley C. B., Miner P. B., Jr Seronegative juvenile rheumatoid arthritis and mast cell-associated gastritis. Arthritis Rheum. 1991 Jan;34(1):106–109. doi: 10.1002/art.1780340117. [DOI] [PubMed] [Google Scholar]
  45. Lopez A. F., Eglinton J. M., Gillis D., Park L. S., Clark S., Vadas M. A. Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7022–7026. doi: 10.1073/pnas.86.18.7022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Lopez A. F., Eglinton J. M., Lyons A. B., Tapley P. M., To L. B., Park L. S., Clark S. C., Vadas M. A. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity. J Cell Physiol. 1990 Oct;145(1):69–77. doi: 10.1002/jcp.1041450111. [DOI] [PubMed] [Google Scholar]
  47. Lopez A. F., Lyons A. B., Eglinton J. M., Park L. S., To L. B., Clark S. C., Vadas M. A. Specific binding of human interleukin-3 and granulocyte-macrophage colony-stimulating factor to human basophils. J Allergy Clin Immunol. 1990 Jan;85(1 Pt 1):99–102. doi: 10.1016/0091-6749(90)90229-w. [DOI] [PubMed] [Google Scholar]
  48. MacDonald S. M., Schleimer R. P., Kagey-Sobotka A., Gillis S., Lichtenstein L. M. Recombinant IL-3 induces histamine release from human basophils. J Immunol. 1989 May 15;142(10):3527–3532. [PubMed] [Google Scholar]
  49. Malone D. G., Vikingsson A., Seebruch J. S., Verbsky J. W., Dolan P. W. In vivo effects of nonsteroidal antiinflammatory drugs on rat skin and synovial mast cell-induced vasopermeability. Arthritis Rheum. 1991 Feb;34(2):164–170. doi: 10.1002/art.1780340206. [DOI] [PubMed] [Google Scholar]
  50. Mayer P., Valent P., Schmidt G., Liehl E., Bettelheim P. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates. Blood. 1989 Aug 1;74(2):613–621. [PubMed] [Google Scholar]
  51. McNiece I., Andrews R., Stewart M., Clark S., Boone T., Quesenberry P. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF. Blood. 1989 Jul;74(1):110–114. [PubMed] [Google Scholar]
  52. Minkowski M., Lebel B., Arnould A., Dy M. Interleukin 3 induces histamine synthesis in the human hemopoietic system. Exp Hematol. 1990 Dec;18(11):1158–1163. [PubMed] [Google Scholar]
  53. Oyama Y., Amano T., Hirakawa S., Hironaka K., Suzuki S., Ota Z. Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder? Br J Haematol. 1989 Oct;73(2):276–278. doi: 10.1111/j.1365-2141.1989.tb00269.x. [DOI] [PubMed] [Google Scholar]
  54. Postmus P. E., Gietema J. A., Damsma O., Biesma B., Limburg P. C., Vellenga E., de Vries E. G. Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study. J Clin Oncol. 1992 Jul;10(7):1131–1140. doi: 10.1200/JCO.1992.10.7.1131. [DOI] [PubMed] [Google Scholar]
  55. Povolny B., Lee M., Hall S. Modulation of tartrate-resistant acid phosphatase expression by calcitriol in CSF-induced macrophage colonies. Exp Hematol. 1990 May;18(4):283–288. [PubMed] [Google Scholar]
  56. Risdall R. J., McKenna R. W., Nesbit M. E., Krivit W., Balfour H. H., Jr, Simmons R. L., Brunning R. D. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979 Sep;44(3):993–1002. doi: 10.1002/1097-0142(197909)44:3<993::aid-cncr2820440329>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  57. Sonoda Y., Arai N., Ogawa M. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia. 1989 Jan;3(1):14–18. [PubMed] [Google Scholar]
  58. Travis W. D., Li C. Y., Su W. P. Adult-onset urticaria pigmentosa and systemic mast cell disease. Am J Clin Pathol. 1985 Dec;84(6):710–714. doi: 10.1093/ajcp/84.6.710. [DOI] [PubMed] [Google Scholar]
  59. Valent P., Besemer J., Muhm M., Majdic O., Lechner K., Bettelheim P. Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5542–5546. doi: 10.1073/pnas.86.14.5542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Valent P., Besemer J., Sillaber C., Butterfield J. H., Eher R., Majdic O., Kishi K., Klepetko W., Eckersberger F., Lechner K. Failure to detect IL-3-binding sites on human mast cells. J Immunol. 1990 Nov 15;145(10):3432–3437. [PubMed] [Google Scholar]
  61. Valent P., Schmidt G., Besemer J., Mayer P., Zenke G., Liehl E., Hinterberger W., Lechner K., Maurer D., Bettelheim P. Interleukin-3 is a differentiation factor for human basophils. Blood. 1989 May 15;73(7):1763–1769. [PubMed] [Google Scholar]
  62. Wagemaker G., van Gils F. C., Burger H., Dorssers L. C., van Leen R. W., Persoon N. L., Wielenga J. J., Heeney J. L., Knol E. Highly increased production of bone marrow-derived blood cells by administration of homologous interleukin-3 to rhesus monkeys. Blood. 1990 Dec 1;76(11):2235–2241. [PubMed] [Google Scholar]
  63. Wang M., Friedman H., Djeu J. Y. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol. 1989 Jul 15;143(2):671–677. [PubMed] [Google Scholar]
  64. Wong P. M., Chung S. W., Dunbar C. E., Bodine D. M., Ruscetti S., Nienhuis A. W. Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder. Mol Cell Biol. 1989 Feb;9(2):798–808. doi: 10.1128/mcb.9.2.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Yamaguchi M., Hirai K., Morita Y., Takaishi T., Ohta K., Suzuki S., Motoyoshi K., Kawanami O., Ito K. Hemopoietic growth factors regulate the survival of human basophils in vitro. Int Arch Allergy Immunol. 1992;97(4):322–329. doi: 10.1159/000236140. [DOI] [PubMed] [Google Scholar]
  66. van Gils F. C., Westerman Y., van den Bos C., Burger H., van Leen R. W., Wagemaker G. Pharmacokinetic basis for optimal hemopoietic effectiveness of homologous IL-3 administered to rhesus monkeys. Leukemia. 1993 Oct;7(10):1602–1607. [PubMed] [Google Scholar]
  67. van Leen R. W., Bakhuis J. G., van Beckhoven R. F., Burger H., Dorssers L. C., Hommes R. W., Lemson P. J., Noordam B., Persoon N. L., Wagemaker G. Production of human interleukin-3 using industrial microorganisms. Biotechnology (N Y) 1991 Jan;9(1):47–52. doi: 10.1038/nbt0191-47. [DOI] [PubMed] [Google Scholar]
  68. van Vreeswijk W., Roger J. H., D'Amaro J., Balner H. The major histocompatibility complex of rhesus monkeys, RhL--A. VII. Identification of five new serologically defined antigens. Tissue Antigens. 1977 Jan;9(1):17–30. doi: 10.1111/j.1399-0039.1977.tb01075.x. [DOI] [PubMed] [Google Scholar]
  69. van der Waaij D., Vossen J. M., Altes C. K., Hartgrink C. Reconventionalization following antibiotic decontamination in man and animals. Am J Clin Nutr. 1977 Nov;30(11):1887–1895. doi: 10.1093/ajcn/30.11.1887. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES